Abstract
We thank Drs Feely and Mahmud1 for their comments regarding our published experience of using spironolactone in patients with resistant hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). We are aware that, unlike the 2004 British Hypertension Society guidelines,2 the updated National Institute of Clinical Excellence (NICE)/British Hypertension Society guidelines no longer …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
